Vendor review
HXNet reviews
HXNet reviews from 174 independent lab tests (Tirzepatide, Retatrutide and Cagrilintide): grade A, purity and fill accuracy. Is HXNet legit? See what its vials showed.
Grade A174 independent lab tests0 peptides listed
HXNet's website could not be reached at the last check. Links to the shop are disabled.
What the lab tests show
174 tests on record, newest first. Scores are purity divided by ten.
| Date | Product | Purity | Quantity | Identity | Certificate |
|---|---|---|---|---|---|
| Oct 12, 2026 | Retatrutide | 99.9 % | 30.7 mg of 30 mg (2 %) | Pass | View |
| Sep 24, 2026 | Retatrutide | 99.9 % | 9.99 mg of 10 mg (0 %) | Pass | View |
| Sep 24, 2026 | GHK-Cu | 99.9 % | 44.9 mg of 50 mg (-10 %) | Pass | View |
| Sep 24, 2026 | CJC-1295 | 99.6 % | 4.57 mg of 5 mg (-9 %) | Pass | View |
| Sep 24, 2026 | GHK-Cu | 99.9 % | 99.99 mg of 100 mg (0 %) | Pass | View |
| Aug 15, 2026 | Sermorelin | 99.7 % | 5.3 mg of 5 mg (6 %) | Pass | View |
| Aug 12, 2026 | Tirzepatide | 99.9 % | 28.4 mg of 30 mg (-5 %) | Pass | View |
| Aug 9, 2026 | Tesamorelin | 99.7 % | 11.8 mg of 10 mg (18 %) | Pass | View |
| Jul 20, 2026 | Retatrutide | 99.9 % | 60.1 mg of 60 mg (0 %) | Pass | View |
| Jul 13, 2026 | Tirzepatide | 99.9 % | 18.8 mg of 20 mg (-6 %) | Pass | View |
| Jul 13, 2026 | Retatrutide | 99.9 % | 11.1 mg of 10 mg (11 %) | Pass | View |
| Jul 1, 2026 | Cagrilintide | 98.9 % | 4.95 mg of 5 mg (-1 %) | Pass | View |
| Jun 26, 2026 | Tirzepatide | 99.8 % | 55.8 mg of 60 mg (-7 %) | Pass | View |
| Jun 24, 2026 | BPC-157 | 99.9 % | 8.91 mg of 10 mg (-11 %) | Pass | View |
| Jun 12, 2026 | Semaglutide | 99.8 % | 5.5 mg of 5 mg (10 %) | Pass | View |
| Jun 6, 2026 | TB-500 | 99.7 % | 5.7 mg of 5 mg (14 %) | Pass | View |
| Jun 6, 2026 | BPC-157 | 99.6 % | 9.7 mg of 10 mg (-3 %) | Pass | View |
| Jun 4, 2026 | Retatrutide | 99.6 % | 10 mg of 10 mg (0 %) | Pass | View |
| Jun 2, 2026 | Tirzepatide | 99.9 % | 34.4 mg of 30 mg (15 %) | Pass | View |
| Jun 2, 2026 | Cagrilintide | 89.7 % | 4.86 mg of 5 mg (-3 %) | Pass | View |
| Jun 2, 2026 | Semaglutide | 99.7 % | 16.4 mg of 15 mg (9 %) | Pass | View |
| Jun 2, 2026 | Retatrutide | 99.9 % | 30.4 mg of 30 mg (1 %) | Pass | View |
| May 27, 2026 | Retatrutide | 99.6 % | 12.6 mg of 20 mg (-37 %) | Pass | View |
| May 24, 2026 | Tirzepatide | 60 mg | View | ||
| May 24, 2026 | Tirzepatide | 30 mg | View | ||
| May 24, 2026 | Tirzepatide | 30 mg | View | ||
| May 21, 2026 | Retatrutide | 99.9 % | 19 mg of 20 mg (-5 %) | Pass | View |
| May 18, 2026 | Tirzepatide | 99.9 % | 69.6 mg of 60 mg (16 %) | Pass | View |
| May 15, 2026 | Tirzepatide | 99.8 % | 38.6 mg of 40 mg (-3 %) | Pass | View |
| May 15, 2026 | Tirzepatide | 99.8 % | 40.2 mg of 30 mg (34 %) | Pass | View |
| May 13, 2026 | Tirzepatide | 99.9 % | 40.4 mg of 40 mg (1 %) | Pass | View |
| May 13, 2026 | Tirzepatide | 99.9 % | 19.1 mg of 20 mg (-4 %) | Pass | View |
| May 13, 2026 | Tirzepatide | 99.9 % | 29.8 mg of 30 mg (-1 %) | Pass | View |
| May 11, 2026 | Tirzepatide | 99.9 % | 30.5 mg of 30 mg (2 %) | Pass | View |
| May 11, 2026 | Tirzepatide | 99.9 % | 30.1 mg of 30 mg (0 %) | Pass | View |
| May 8, 2026 | Retatrutide | 99.8 % | 58.3 mg of 60 mg (-3 %) | Pass | View |
| May 8, 2026 | Tirzepatide | 99.8 % | 120.9 mg of 100 mg (21 %) | Pass | View |
| May 2, 2026 | Tirzepatide | 99.8 % | 59.3 mg of 60 mg (-1 %) | Pass | View |
| May 2, 2026 | Tirzepatide | 99.6 % | 33.8 mg of 30 mg (13 %) | Pass | View |
| Apr 30, 2026 | Retatrutide | 99.8 % | 24.1 mg of 20 mg (21 %) | Pass | View |
| Apr 28, 2026 | Semaglutide | 99.9 % | 9.91 mg of 10 mg (-1 %) | Pass | View |
| Apr 28, 2026 | Tirzepatide | 99.9 % | 21 mg of 20 mg (5 %) | Pass | View |
| Apr 28, 2026 | Retatrutide | 99.9 % | 28.9 mg of 30 mg (-4 %) | Pass | View |
| Apr 23, 2026 | TB-500 | 99.9 % | 10.3 mg of 10 mg (3 %) | Pass | View |
| Apr 21, 2026 | Tirzepatide | 99.8 % | 56.7 mg of 50 mg (13 %) | Pass | View |
| Mar 29, 2026 | Retatrutide | 99.8 % | 30.8 mg of 30 mg (3 %) | Pass | View |
| Mar 29, 2026 | Cagrilintide | 99.8 % | 5.3 mg of 5 mg (6 %) | Pass | View |
| Mar 18, 2026 | Cagrilintide | 99.9 % | 4.76 mg of 5 mg (-5 %) | Pass | View |
| Mar 10, 2026 | BPC-157 | 99.9 % | 15.3 mg of 20 mg (-24 %) | Pass | View |
| Mar 10, 2026 | GHK-Cu | 99.9 % | 96.9 mg of 100 mg (-3 %) | Pass | View |
| Mar 6, 2026 | Retatrutide | 99.9 % | 20 mg of 20 mg (0 %) | Pass | View |
| Mar 6, 2026 | Tirzepatide | 99.9 % | 26.5 mg of 30 mg (-12 %) | Pass | View |
| Mar 6, 2026 | Tirzepatide | 99.9 % | 46.9 mg of 60 mg (-22 %) | Pass | View |
| Mar 6, 2026 | Tirzepatide | 99.9 % | 18.5 mg of 20 mg (-8 %) | Pass | View |
| Mar 6, 2026 | Retatrutide | 99.9 % | 20.6 mg of 20 mg (3 %) | Pass | View |
| Mar 6, 2026 | Cagrilintide | 99.9 % | 4.98 mg of 5 mg (0 %) | Pass | View |
| Mar 4, 2026 | Tesamorelin | 99.6 % | 3.6 mg of 5 mg (-28 %) | Pass | View |
| Mar 4, 2026 | Tirzepatide | 99.9 % | 20.8 mg of 20 mg (4 %) | Pass | View |
| Mar 4, 2026 | Tirzepatide | 99.06 % | 10.2 mg of 10 mg (2 %) | Pass | View |
| Mar 4, 2026 | Retatrutide | 99.7 % | 14.4 mg of 15 mg (-4 %) | Pass | View |
What HXNet sells
No current listings on record.
About HXNet
Finnrick has tested 174 samples from HXNet across 12 products.